NEW! If you don't understand one of the words in this article,
just double-click it.
A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.
November 20, 2007
HIV Med Market Boom
A new financial analysis of the HIV drug market highlights the potential reshuffling of market positions as the patents of AIDS drugs expire (money.cnn.com, 11/19).
It is estimated that the $8 billion HIV drug market will expand by approximately 50 percent by 2016, says analyst Mansi Shah of research company Datamonitor.
With two thirds of current HIV drug patents expiring in the next 10 years, more and more companies are expected to challenge top drugmakers. In addition, experts attribute the booming market to advanced HIV medications, which will keep those living with the virus—and the drug market—alive and well for years to come.
“HIV patients live much longer,” says Jason Zhang, an analyst for BMO Capital Markets. “They have the disease for life, and that’s why the market is growing.”
Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Previous Comments:
comments 1 - 3 (of 3 total)
Zachary, Denver, CO, 2007-11-28 15:36:46
Better that the market not be growing? Developing a cure for a disease by no means ensures the eradication of that disease. Someone somewhere will always need meds. A manufacturer who could produce a cure for HIV infection would stand to reap enormous profits.
Ryan, Queens, 2007-11-28 15:18:40
I think the drug companies are more focused on trying to maintain HIV/AIDS as to curing it. We all know for a fact that drug companies moto is "There isn't any PROFITS in a CURE" So I am happy about the new drugs and what they do but VERY concerned about where this is going.
Leonardo, Middletown, NJ, 2007-11-25 07:50:21
"They have the disease for life, and that's why the market is growing."
Does the prospect of having lifelong customers, why would any drug company want to develop an actual cure? Scary.
